Pages that link to "Q69419589"

The following pages link to Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form (Q69419589):

Displaying 42 items.

• Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator (Q24537624) (← links)
• GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors (Q24646387) (← links)
• The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing (Q24646988) (← links)
• Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity (Q28200121) (← links)
• Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein (Q28262754) (← links)
• 16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity (Q28285029) (← links)
• Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues (Q28366589) (← links)
• Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor (Q33923267) (← links)
• Antioxidant: a new role for RU-486 and related compounds (Q34157921) (← links)
• Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation (Q34260147) (← links)
• Progesterone receptor transcription and non-transcription signaling mechanisms (Q34282690) (← links)
• Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. (Q34463159) (← links)
• Regulation of gene expression by steroid hormones (Q35234340) (← links)
• Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. (Q35798138) (← links)
• Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo (Q35909300) (← links)
• Molecular mechanism of RU 486 action: a review (Q36249723) (← links)
• The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways (Q36299014) (← links)
• Mechanisms controlling steroid receptor binding to specific DNA sequences (Q36415631) (← links)
• p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization (Q36551958) (← links)
• Repression of the alpha-fetoprotein gene promoter by progesterone and chimeric receptors in the presence of hormones and antihormones (Q36726228) (← links)
• Two pathways for prostaglandin F2 alpha synthesis by the primate periovulatory follicle (Q37129894) (← links)
• Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding (Q37337779) (← links)
• Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element (Q37369306) (← links)
• Pregna-D'-pentarane structure influences progesterone receptor affinity for DNA. (Q38290107) (← links)
• Specific binding of progesterone receptor to progesterone‐responsive elements does not require prior dimerization (Q38319261) (← links)
• Thyroid hormone alters the DNA binding properties of chicken thyroid hormone receptors alpha and beta (Q38325856) (← links)
• A 361 base pair region of the rat FSH-beta promoter contains multiple progesterone receptor-binding sequences and confers progesterone responsiveness (Q38339260) (← links)
• Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: fantasy or reality (Q38359525) (← links)
• Progesterone enhances target gene transcription by receptor free of heat shock proteins hsp90, hsp56, and hsp70. (Q40641073) (← links)
• Molecular biology of breast carcinoma (Q40759266) (← links)
• Differential activity of progesterone and glucocorticoid receptors on mouse mammary tumor virus templates differing in chromatin structure (Q41108970) (← links)
• Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists (Q41584934) (← links)
• Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones (Q41643600) (← links)
• Identification of a functional intermediate in receptor activation in progesterone-dependent cell-free transcription (Q41731206) (← links)
• Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor (Q42513872) (← links)
• The dissociation rate of estrogen receptor alpha from the consensus estrogen response element (Q43590321) (← links)
• ZK98299—A new antiprogesterone: Biochemical characterization of steroid binding parameters in the calf uterine cytosol (Q43806911) (← links)
• Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use. (Q45974241) (← links)
• Epitope mapping of the anti-human progesterone receptor monoclonal antibody, AB-52 (Q67704894) (← links)
• Inhibition of oxidative modification of proteins by RU486 (Q71383441) (← links)
• Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes (Q73016861) (← links)
• An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding (Q73962652) (← links)